Completed
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
NCT00631163
- Conditions
- Chronic Anemia, Iron Metabolism Disorders, Iron Overload, +3 more
- Locations
-
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Nagoya, Aichi-ken, Japan
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Sapporo, Hokkaido, Japan